BLT
Click for more information
0.00% 2.6¢ benitec biopharma limited

Interesting article on GT and pharma, page-21

  1. J8
    14,558 Posts.
    lightbulb Created with Sketch. 826
    clock Created with Sketch.
    14/11/15
    00:53
    Post #: 16394354
    Isn't the next trial going to be phase 2b and phase 3 anyway?

    Success there would give them a chance at approval. Which means a deal will come before it starts. I don't reckon they will need cohort five and they will continue with the fourth dose. Then a deal.... then the next trial will be run here in Sydney and also over there in the States.
    BLT Price at posting: 38.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
TG6 TG Metals reports high grade lithium hits approaching 3% at Jaegermeister
right-arrow Created with Sketch.
NEWS Bitcoin: Current State of Play & Where to Next | Swyftx
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.